Literature DB >> 823107

Preparation of a purified antigenic cholera toxoid.

R Germanier, E Fürer, S Varallyay, T M Inderbitzin.   

Abstract

Purified cholera enterotoxin was prepared by methods described by Finkelstein and Lo Spalluto (1970). This toxin was detoxified by treatment with heat and formaldehyde. Heating cholera toxin at 60 C for 25 min resulted in the formation of a polymer named procholeragenoid by Finkelstein et al. (1971). The weak toxic activity of this product was removed by treatment with formalin. No residual toxicity could be demonstrated in formalinized procholeragenoid by the rabbit ileal loop assay and the highly sensitive rabbit skin tests. This toxoid was nevertheless at least as antigenic in the rabbit as was the toxin. No reversion to toxicity was observed in vivo and in vitro at 4 C. The toxicity of formalinized procholeragenoid never exceeded 1/5,000 to 1/10,000 that of the toxin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 823107      PMCID: PMC420821          DOI: 10.1128/iai.13.6.1692-1698.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.

Authors:  R A Cash; S I Music; J P Libonati; J P Craig; N F Pierce; R B Hornick
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

2.  Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.

Authors:  J Holmgren; A Andersson; G Wallerstrom; O Ouchterlony
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

3.  Protection against experimental cholera by antitoxin.

Authors:  N F Pierce; E A Kaniecki; R S Northrup
Journal:  J Infect Dis       Date:  1972-12       Impact factor: 5.226

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Development of a purified cholera toxoid. II. Preparation of a stable, antigenic toxoid by reaction of purified toxin with glutaraldehyde.

Authors:  R S Rappaport; G Bonde; T McCann; B A Rubin; H Tint
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

6.  Experiments with cholera toxin detoxified with glutaraldehyde.

Authors:  M Saletti; A Ricci
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

7.  Response of monkeys to immunization with cholera toxoid, toxin, and vaccine: reversion of cholera toxoid.

Authors:  R S Northrup; F V Chisari
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

8.  Procholeragenoid: an aggregated intermediate in the formation of choleragenoid.

Authors:  R A Finkelstein; K Fujita; J J LoSpalluto
Journal:  J Immunol       Date:  1971-10       Impact factor: 5.422

9.  Production of highly purified choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  14 in total

1.  Ageing compromises gastrointestinal mucosal immune response in the rhesus monkey.

Authors:  L D Taylor; C K Daniels; D L Schmucker
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

2.  Simple method for purifying choleragenoid, the natural toxoid of Vibrio cholerae.

Authors:  J J Mekalanos; R J Collier; W R Romig
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

3.  Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers.

Authors:  S Migasena; P Pitisuttitham; P Suntharasamai; B Prayurahong; W Supanaranond; V Desakorn; R E Black
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

4.  Protection against experimental cholera by oral or parenteral immunization.

Authors:  J W Peterson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

Review 5.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.

Authors:  M M Levine; J B Kaper; R E Black; M L Clements
Journal:  Microbiol Rev       Date:  1983-12

6.  Protection against colibacillosis in neonatal piglets by immunization of dams with procholeragenoid.

Authors:  E Fürer; S J Cryz; F Dorner; J Nicolet; M Wanner; R Germanier
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

7.  K88-mediated binding of Escherichia coli outer membrane fragments to porcine intestinal epithelial cell brush borders.

Authors:  J M Middeldorp; B Witholt
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Enhanced mucosal priming by cholera toxin and procholeragenoid with a lipoidal amine adjuvant (avridine) delivered in liposomes.

Authors:  N F Pierce; J B Sacci
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

9.  Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.

Authors:  S J Cryz; E Fürer; R Germanier
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Procholeragenoid: a safe and effective antigen for oral immunization against experimental cholera.

Authors:  N F Pierce; W C Cray; J B Sacci; J P Craig; R Germanier; E Fürer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.